Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: Binding properties of lipid A interaction with TLR4-MD-2. Ba/F3 stable transfectant expressing CD14 and TLR4-MD-2 (10 8 cells/10 ml medium) were stimulated with various concentrations of 3 H-lipid A (0.003, 0.01, 0.03, 0.1, 0.3, 1, 3, and 10 μCi) for 30 min at 37°C. After washing, cells were subjected to immunoprecipitation with Sa15-21 or with MTS510. Precipitated radioactivity was counted by a liquid scintillation counter (Aloka). Specific binding was obtained by subtracting bound cpm with MTS510 from that with Sa15-21. Bound lipid A (cpm) was plotted against input lipid A (cpm) in panel a. Scatchard plot is shown in panel b. Two independent experiments were conducted and similar results were obtained.

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Binding Assay, Transfection, Expressing, Immunoprecipitation, Radioactivity

Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: No detectable LPS binding to cells expressing TLR4-MD-2 without CD14. Ba/F3 stable transfectants were stained with anti–TLR4-MD-2 mAb (MTS510, left) or anti-CD14 mAb (4C1, middle), followed by goat anti–rat IgG-PE. (right) Ba/F3 transfectants were stimulated with 1 μg/ml LPS at 37°C for 30 min, washed, and stained with anti-LPS mAb, followed by goat anti–mouse IgG-FITC. All the open histograms depict staining with the second reagent alone.

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Binding Assay, Expressing, Staining

Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: LPS down-regulates MTS510 binding to cell surface TLR4-MD-2. Ba/F3 cells expressing TLR4-MD-2 (left) or CD14 + TLR4-MD-2 (middle), or a macrophage line RAW264 (right) were stimulated with medium alone, 1 μg/ml lipid A, 10 μg/ml peptidoglycan (PGN), or 100 μM CpG DNA as indicated. After washing, cells were stained with biotinylated MTS510 followed by streptavidin-PE.

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Binding Assay, Expressing, Staining

Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: A novel mAb to TLR4-MD-2 reveals the LPS-triggered change of cell surface TLR4-MD-2. (a) Immunoprecipitation with anti-flag (top) or Sa15-21 (bottom) was conducted with Ba/F3 transfectants expressing the indicated molecules (Materials and Methods). The precipitates were probed with rabbit anti–mouse TLR4 sera followed by goat anti–rabbit alkaline phosphatase. Only immature, smaller TLR4 is detected in cells expressing TLR4 alone (top, TLR4f and CD14/TLR4f), because TLR4 without MD-2 cannot reach the cell surface. (b) Ba/F3 transfectants expressing CD14 and TLR4-MD-2 were stimulated with medium alone, 1 μg/ml lipid A, or 1 μg/ml LPS at 37°C for 30 min. Cells were stained with biotinylated MTS510 mAb or Sa15-21 as indicated, followed by streptavidin-PE. Open histograms depict staining with streptavidin-PE alone. (c) Ba/F3 cells expressing TLR4-MD-2 and CD14 (top) or RAW264 (bottom) were stimulated with medium, 2 μg/ml LPS, or 2 μg/ml lipid A antagonist E5531 as indicated at 37°C for 30 min. After washing, cells were subjected to cell surface biotinylation, detergent lysis, immunoprecipitation with MTS510 mAb (right three lanes) or Sa15-21 mAb (left three lanes), SDS-PAGE (7.5% polyacrylamide under nonreducing conditions), and electroblotting. Precipitated cell surface TLR4 was probed with streptavidin–alkaline phosphatase conjugate.

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Immunoprecipitation, Expressing, Staining, Lysis, SDS Page

Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: Lipid A–TLR4-MD-2 complexes. (a) Ba/F3 cells expressing TLR4-MD-2 and CD14 (10 8 /10 ml sample) were incubated with 5 μg/ml lipid A at 37°C for 30 min. Cells were subjected to washing, detergent lysis, immunoprecipitation (with mAbs to TLR4-MD-2, MTS510, and Sa15-21, or an mAb to CD14, Sa2-8, and SDS-PAGE [17.5% for lipid A, 10% for CD14, and 7.5% for TLR4; under nonreducing conditions]), and electroblotting. Precipitates were probed with anti-TLR4 polyclonal Ab, anti-CD14 mAb (Sa2-8), or anti–lipid A mAb, followed by alkaline phosphatase–conjugated secondary antibodies. Nonspecific signals detecting IgG heavy chains were observed in the precipitates probed with anti-CD14 mAb (left four lanes). (b) A variety of Ba/F3 stable transfectants (2.5 × 10 7 /sample) were stimulated with 3 H-lipid A (0.75 μCi/sample) at 37°C for 30 min. Cells were subjected to washing, detergent lysis, and immunoprecipitation with MTS510, Sa15-21, anti-flag, or anti-CD14 mAbs. Precipitated radioactivity was counted by scintillation counter. Similar results were obtained from three independent experiments using 3 H-lipid A.

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Expressing, Incubation, Lysis, Immunoprecipitation, SDS Page, Radioactivity

Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: LPS–CD14 complexes are disrupted by detergents. Supernatant from Ba/F3 cells expressing 1 ml CD14 (cultured up to 4–5 × 10 6 /ml) was incubated with 3 μg/ml LPS at 37°C for 30 min; sCD14 in the supernatant from Ba/F3 cells expressing CD14 was immunoprecipitated with anti-CD14 mAb (4C1). The indicated detergents (1% Triton X-100, 0.5% N -octyl-β- d -glucoside, and 1% Brij98) were included before immunoprecipitation. Precipitated LPS or CD14 was probed with anti-LPS mAb and anti-CD14 mAb (Sa2-8), followed by alkaline phosphatase–conjugated secondary antibodies.

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Expressing, Cell Culture, Incubation, Immunoprecipitation

Journal: The Journal of Experimental Medicine

Article Title: Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

doi: 10.1084/jem.20031076

Figure Lengend Snippet: E5531 acts on LPS interaction with TLR4-MD-2 at a concentration that does not affect LPS binding to mCD14. (a) Ba/F3 cells expressing TLR4-MD-2 and CD14 were pretreated with or without E5531 (indicated concentration) at 37°C for 30 min. Cells were stimulated with medium alone or 3 μg/ml LPS at 37°C for 30 min. After washing, cells were stained with biotinylated MTS510 mAb followed by streptavidin-PE (left and middle columns), or with anti-LPS followed by goat anti–mouse IgG-FITC (right column). Open histograms depict staining with the secondary reagent alone. (b) 3 μg/ml LPS with indicated concentrations of E5531 was added to the supernatant from Ba/F3 cells expressing CD14. sCD14 in the supernatant was precipitated with anti-CD14 mAb, followed by immunoprobing with anti-LPS (top) or anti-CD14 (bottom). (c) After treatment with E5531 and LPS as in panel a, cells were subjected to cell surface biotinylation, washing, detergent lysis, immunoprecipitation with Sa15-21, SDS-PAGE (polyacrylamide gel:18.0% for LPS and 7.5% for TLR4; under nonreducing conditions), and electroblotting. Precipitated LPS (top) and cell surface TLR4 (bottom) were probed with anti-LPS mAb or alkaline phosphatase–conjugated streptavidin, respectively. (d) After treatment with LPS and E5531 as in panel c, cells were subjected to detergent lysis, SDS-PAGE, electroblotting, and immunoprobing IkBα (top) or actin (bottom).

Article Snippet: The mAbs used were as follows: rat anti–mouse TLR4-MD-2 (MTS510 and Sa15-21); rat anti–mouse CD14, 4C1 ( ); or anti-LPS (Hycult Biotechnology).

Techniques: Concentration Assay, Binding Assay, Expressing, Staining, Lysis, Immunoprecipitation, SDS Page

Journal: STAR Protocols

Article Title: Murine brain tumor microenvironment immunophenotyping using mass cytometry

doi: 10.1016/j.xpro.2022.101357

Figure Lengend Snippet: Antibody master mix

Article Snippet: Anti-Mouse CD14 (Sa14-2)-156Gd—100 Tests , Fluidigm , SKU# 3156009B.

Techniques:

Journal: STAR Protocols

Article Title: Murine brain tumor microenvironment immunophenotyping using mass cytometry

doi: 10.1016/j.xpro.2022.101357

Figure Lengend Snippet:

Article Snippet: Anti-Mouse CD14 (Sa14-2)-156Gd—100 Tests , Fluidigm , SKU# 3156009B.

Techniques: Purification, Recombinant, Red Blood Cell Lysis, Centrifugation, Staining, Electron Microscopy, Antibody Labeling, Software, Sterility, Spectrophotometry

Journal: NPJ Vaccines

Article Title: The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control

doi: 10.1038/s41541-021-00338-z

Figure Lengend Snippet: Licensed Japanese encephalitis (JE) vaccines.

Article Snippet: Live chimeric , Vero , JE SA 14-14-2/yellow fever 17D , Thailand: Government Pharmaceutical Organization-Merieux Biological Products Co. , Single dose at ≥9 months of age a , n/a.

Techniques: Vaccines

Journal: Vaccines

Article Title: Immunization in the Asia-Pacific region

doi: 10.1016/B978-1-4557-0090-5.00069-0

Figure Lengend Snippet: Vaccines and Vaccine Manufacturers in Asia *

Article Snippet: Zhejiang Tianyuan , Influenza, inactivated split (seasonal and H1N1 pandemic) HFRS, inactivated bivalent, primary Mongolian gerbil kidney cell (Z10,Z37 strains) JE, inactivated, PHK cell (SA 14 -14-2) , Meningococcal A and C, PS Meningococcal A, C, Y, W135 PS.

Techniques: Vaccines, Virus, Recombinant, Purification